PHP
OM icon

Parkman Healthcare Partners’s Outset Medical OM Stock Holding History

Parkman Healthcare Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-454,512
Closed -$6.42M – 108
2025
Q3 		$6.42M Sell
454,512
-94,540
-17% -$1.47M 0.67% 57
2025
Q2 		$10.5M Buy
549,052
+317,953
+138% +$4.96M 1.21% 28
2025
Q1 		$2.56M Buy
+231,099
New +$2.76M 0.3% 70
2022
Q2 		– Sell
-5,440
Closed -$3.71M – 86
2022
Q1 		$3.71M Buy
5,440
+2,286
+72% +$1.38M 1.08% 35
2021
Q4 		$2.18M Sell
3,154
-202
-6% -$149K 0.48% 54
2021
Q3 		$2.49M Sell
3,356
-1,333
-28% -$908K 0.63% 50
2021
Q2 		$3.52M Buy
4,689
+356
+8% +$272K 0.77% 43
2021
Q1 		$3.54M Buy
4,333
+2,452
+130% +$1.89M 0.82% 40
2020
Q4 		$1.6M Buy
1,881
+1,414
+303% +$1.09M 0.41% 63
2020
Q3 		$350K Buy
+467
New +$384K 0.09% 84

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Parkman Healthcare Partners's OM Position: Q4 2025 in Review

Parkman Healthcare Partners sold out of Outset Medical (OM) in Q4 2025, closing a stake of 454,512 shares — an estimated $6.42M sold.

Parkman Healthcare Partners first reported a position in OM in Q3 2020 and held it in 10 quarters. The position peaked at $10.5M in Q2 2025. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

  • Parkman Healthcare Partners reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 454,512 Outset Medical shares in Q4 2025, an estimated $6.42M.
  • Parkman Healthcare Partners first reported a position in Outset Medical in Q3 2020 and held it in 10 quarters.
  • Parkman Healthcare Partners's Outset Medical position peaked at $10.5M in Q2 2025.
  • 100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Parkman Healthcare Partners's 13F filing for Q4 2025, filed 17 Feb 2026.